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ABSTRACT Bacteria host an arsenal of antagonism-mediating molecules to combat
for ecologic space. Bacteriocins represent a pivotal group of secreted antibacterial
peptides and proteins assisting in this ﬁght, mainly eliminating relatives. Colicin M, a
model for peptidoglycan-interfering bacteriocins in Gram-negative bacteria, appears
to be part of a set of polymorphic toxins equipped with such a catalytic domain
(ColM) targeting lipid II. Diversifying recombination has enabled parasitism of differ-
ent receptors and has also given rise to hybrid bacteriocins in which ColM is associ-
ated with another toxin module. Remarkably, ColM toxins have recruited a diverse
array of immunity partners, comprising cytoplasmic membrane-associated proteins
with different topologies. Together, these ﬁndings suggest that different immunity
mechanisms have evolved for ColM, in contrast to bacteriocins with nuclease activi-
ties.
KEYWORDS bacteriocin, colicin M, diversifying recombination/selection, lipid II,
periplasm, toxin-immunity module
Bacteriocin production represents a proﬁcient bacterial strategy to eliminate phy-logenetically related rivals, competing for nutrients and space. These ribosomally
encoded antibacterial peptides and proteins, diverse in size—ranging from peptides to
large multiprotein complexes—and mode of action, are ubiquitous and fulﬁll a pivotal
role in colonizing different niches such as rhizosphere and gut (1–4). Bacteriocins
identiﬁed in several proteobacterial genera, including Escherichia, Pseudomonas, and
Yersinia, are also structurally very diverse, and a major subset of these molecules adopt
a modular organization characteristic of polymorphic toxins. They consist of a receptor-
binding domain (RBD) allowing docking onto the surface of a target cell, a moiety
enabling transfer across the membrane, and a variable carboxy-terminal toxin domain
mediating killing by different mechanisms (5–9).
Bacteriocinogenic strains need to impede the lethal intracellular activity of the
toxins that they produce. For nuclease bacteriocins acting in the cytoplasm, this is
achieved via coexpression of dedicated immunity genes encoding small proteins (80 to
160 amino acids [aa]) that attach to cognate toxin modules with strict speciﬁcity and
high afﬁnity (7, 10). Upon contact with target cells, this one-on-one protein association
is lost (11, 12). For bacteriocins acting at the periplasmic level, such as pore formers and
certain enzymes interfering with peptidoglycan metabolism, an integral membrane or
membrane-anchored protein transiently impedes the bacteriocin’s action during secre-
tion by (an) unknown mechanism(s). Colicins from Escherichia coli (8) and S-type
pyocins from Pseudomonas aeruginosa (6) currently serve as model systems in Gram-
negative bacteria for studying immunity functions, toxin activities, receptor interac-
tions, and bacteriocin-import processes.
Enzymatic attack on the bacterial inner fortress wall. Colicin M from E. coli is one
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of the smallest modular bacteriocins studied to date. Its carboxy-terminal catalytic
domain (ColM) displays phosphatase activity and cleaves the peptidoglycan building
block lipid II, accessible from the periplasm. This leads to accumulation of undecaprenol
(C55-OH) and 1-pyrophospho-MurNAc (N-acetylmuramic acid)-GlcNAc (N-acetylglucos-
amine), with MurNAc carrying the stem pentapeptide, which cannot be reused for
murein biosynthesis (13–15). This enzymatic activity distinguishes the “protein antibi-
otic” ColM from antibiotics of different chemical classes acting on lipid II (16), and
pesticin, which cleaves the glycan chain of murein (17). The recently described strep-
tococcal LXG toxin TelC displays similar lipid II-degrading activity as ColM but adopts
a different fold (18, 19).
ColM domain-encoding bacteriocin genes have also been characterized in Burkhold-
eria (20), Pectobacterium (21), and Pseudomonas (22–25), here termed ColM-type burk-
hocins, pectocins, and pseudocins, respectively (Table 1). Such putative bacteriocin
genes are also found in other genera, mainly in the Enterobacteriaceae (e.g., Enterobac-
ter, Klebsiella, Salmonella, and Serratia). Notably, whereas colicin M genes are plasmid
encoded in E. coli and some other Enterobacteriaceae (such as Citrobacter and Shigella),
usually joined upstream by a colicin B pore-former–immunity gene tandem (26),
ColM-type bacteriocin genes in other genera reside on chromosomes, often within or
in close proximity to a mobile context or regions prone to recombination events, such
as tailocin units, genomic islands, and transposases (21, 22, 24, 27).
The catalytic mechanism of ColM-mediated lipid II degradation remains elusive,
although mutagenesis studies with E. coli and P. aeruginosa ColM bacteriocins allowed
the identiﬁcation of a DXYDX5HR motif required for the hydrolase function (14, 28).
Some degeneracy in this signature sequence appears to exist, e.g., in the ColM-type
burkhocin from Burkholderia ambifaria MEX-5 as DXFKX5R (see Fig. S1 in the supple-
TABLE 1 Summary of functionally characterized bacteriocins equipped with a ColM domainf
ColM
type Species Strain
Bacteriocin ColM immunity protein
Replicon ReceptorName
Size
(aa) Domain(s) Type
Size
(aa) Domain
imm
positione
ColM Escherichia
coli
SMS-3-5
(pSMS35_130)
Colicin M 271 PF14859a Cmi 117 PF13995d D () Plasmid FhuA
Pectobacterium
carotovorum
PC1 Pectocin M1 268 PF00111,b
PF14859
Cmi* 117 PF13995 D () Chromosome FusA
PBR1692 Pectocin M2 271 PF00111,
PF14859
Cmi* 123 PF13995 ? Chromosome FusA*
JJ692 Pyocin M1
(PaeM)
289 PF14859 PmiA* 142 ND D () Chromosome FiuA*
Pseudomonas
aeruginosa
NCTC10332 Pyocin M1
(PaeM)
289 PF14859 PmiA 142 ND D () Chromosome FiuA
BL03 Pyocin M4
(PaeM4)
342 PF14859 PmiC* 232 ND D () Chromosome ?
Pseudomonas
ﬂuorescens
Q8r1-96 PﬂM 271 PF14859 PmiA 142 ND D () Chromosome FiuA
Pseudomonas
synxantha
BG33R PmnH 462 PF14859,
PF01024c
? ? ? ? Chromosome FiuA
Pseudomonas
syringae
DC3000 Syringacin M
(PsyM/SyrM)
276 PF14859 PmiA 135 ND D () Chromosome FiuA*
ColM Burkholderia
ambifaria
MEX-5 Burkhocin
M1 (BurM1)
379 PF14859 BmiA 110 ND U () Chromosome ?
AMMD Burkhocin
M2 (BurM2)
372 PF14859 BmiB 124 ND D () Chromosome ?
aPF14859, colicin M (ColM).
bPF00111, Fer2 (2Fe-2S iron-sulfur cluster binding domain).
cPF01024, colicin (colicin pore-forming domain).
dPF13995, YebF (YebF-like protein).
eImmunity gene (imm) positions: D, downstream; U, upstream; , same strand; , opposite strand.
fPutative immunity partners and/or receptors are marked with an asterisk. ND, not detected; ?, unknown. Pyocin M1 proteins from JJ692 and NCTC10332 share 90%
pairwise amino acid identity. PFAM families are indexed a-b-c-d.
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mental material). For this protein, phosphatase activity via a lipid II hydrolase assay
remains to be assessed (20). Interestingly, even in a mutated pectocin M1 protein where
lipid II degradation is abolished, the ColM module may still provoke cellular lysis when
secreted to the periplasm, indicating that inhibition by ColM domains may not be
based solely on the known catalytic activity (29). This is reminiscent of the collateral
damage to membranes and membrane-bound complexes that can be caused by lipid
II-binding antibiotics (16). Signiﬁcant variation in the relative positioning of the side
chains of the ColM signature residues has been observed as well (Fig. S2) (23, 30–32).
Such structural ﬂexibility suggests reorientation of these key residues to accommodate
binding of lipid II and to act in a concerted way (23, 31, 32). ColM hydrolase activity
does not seem to be highly speciﬁc, since cleavage of peptidoglycan precursors from
Gram-positive bacteria was noted too (31, 33).
Polyphyletic nature of the enzyme module. Phylogenetic analysis of ColM do-
mains (Pfam PF14859) extracted from characterized bacteriocins and homologues
reveals that, with few exceptions, they are afﬁliated with one of two major clades, here
termed ColM and ColM (Table 1; Fig. 1). In addition to E. coli and a number of
enterobacterial species, ColM domain representatives occur in several other gamma-
proteobacteria, including pectobacteria producing the ColM-type pectocins (21) and
pseudomonads. In the latter genus, a large number of diverged ColM domains can be
discerned, reﬂecting its enormous phylogenomic divergence (34), but the ColM signa-
ture motif can be recognized well in most catalytic domains (Fig. S1). Two notable
exceptions are those in which the ColM domain is not present at the carboxy terminus.
In Pseudomonas synxantha BG33R and about 10 other strains, the ColM domain (motif
HXYDX5FK) is fused at the C terminus with a ColN-related pore-forming domain (6, 35,
36). Bacteriocin functionality of this hybrid toxin, termed PmnH, has been demon-
strated, although the exact contribution of the ColM domain in the antibacterial
function remains elusive (37). Conceivably, the recruitment of a second killing module
would offer a competitive advantage for producer strains since cellular death may be
circumvented only when targeted strains express two compatible immunity proteins.
For another hybrid bacteriocin organization found in Pseudomonas sp. strain NFR02, the
ColM domain is followed by a pyocin S domain (Pfam PF06958)—involved in mem-
brane translocation of numerous nuclease bacteriocins (38)—and a toxin-immunity
module previously identiﬁed in carocin D (no Pfam domain assigned) (39). The latter
killer unit acts as a DNase but is distinct from HNH- and non-HNH-type DNases (7, 10,
40). Signiﬁcant deviations from the ColM motif (IXYNX5LK) in this second hybrid
(tentatively named PmdH) suggest that in this protein the phosphatase function is
abrogated (Fig. S1).
The ColM clade is populated by fewer representatives, mainly originating from
Burkholderia and Pseudomonas, with some Pseudomonas strains carrying bacteriocin
genes of both types, i.e., a ColM- and a ColM-type gene, at unlinked locations (for
example, Pseudomonas syringae pv. morsprunorum M302280) (24). No crystal structure
is available yet for a ColM representative. An interesting observation is that ColM-type
burkhocins are consistently equipped with a short carboxy-terminal extension of ~30 aa
(20), not part of the ColM module. The exact role of this extra segment remains elusive,
though it likely does not contribute to the hydrolase or immunity function (see below),
given its absence in ColM-type bacteriocins from Pseudomonas, Stenotrophomonas,
and Luteibacter.
Different routes for bacteriocin release. Bacteriocin secretion is a costly trait for
producer strains since this step requires cell lysis. Colicins are generally released to the
medium following expression of a lysis gene in close proximity to the bacteriocin
genes. However, such a gene is not present near colM in Escherichia coli, nor is this the
case for chromosome-carried colM genes (8, 41). This raises the question of how these
compounds can be secreted by the cell. Earlier, it was demonstrated that colicins
lacking an adjacent lysis module may take advantage of a lytic cassette of a prophage
encoded elsewhere in the genome (42), and similar secretion “piggybacking” via
prophage or tailocin clusters has been suggested for other midsize bacteriocins as well
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(27). Given the high cost of lytic release, only a fraction of a total cell population is
therefore sacriﬁced for compound release, as demonstrated for a colicin A-E2-E7 system
(43). Among ColM-type bacteriocins, only the burkhocins are preceded by a cleavable
secretion signal sequence (20), indicative of membrane passage via the Sec pathway.
FIG 1 Phylogeny of ColM domains derived from characterized and putative bacteriocins. Maximum likelihood phylogenetic tree (PhyML, JTT substitution model) of
ColM domains of selected bacteriocins: highly homologous sequences per genus (80% pairwise amino acid identity for full-length proteins) are represented by one
sequence only. Bootstrap values (percentages of 1,000 replicates) higher than 50 are shown at the branches; the scale bar represents 0.5 substitutions per site.
ColM-type, ColM-type, and ColMs with unassigned positioning are shown on a red, a wheat-color, and a white background, respectively. Functionally characterized
ColM bacteriocins are marked in blue, and other enterobacterial ColMs are marked in orange. Species abbreviations are deﬁned in the legend to Fig. S1. Citrobacter
freundii AMA 948, Shigella boydii 1221, Klebsiella pneumoniae k1004, and Salmonella enterica subsp. enterica DT104 encode a ColM bacteriocin highly homologous to
colicin M from Escherichia coli (~99% pairwise amino acid identity) and are not displayed at the node of “Ecol SMS-3-5” for legibility. ColM domains that are part of
a hybrid bacteriocin with dual toxin architecture are grouped by a dashed ellipse. Enterobacterial ColM domains from the Cmi-joined clade share ~53% pairwise amino
acid identity; more remote members in Pantoea and Erwinia share lower amino acid identities with their enterobacterial counterparts (23 to 42% pairwise amino acid
identity). ColMs from pseudomonads in the ColM clade share ~37% pairwise amino acid identity. The type of (putative) immunity partner for ColM—encoded
downstream or upstream or separated from the bacteriocin—is displayed next to the clade (delineated by arcs).
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This was previously observed for other proteobacterial bacteriocin systems as well, such
as certain lectin-like bacteriocins (44, 45). It remains unclear, however, what evolution-
ary drivers determined the incorporation of signal sequences and what environmental
cues trigger ColM-type bacteriocin expression.
A distinct polymorphic toxin family generated by diversifying recombination.
Initiation of import of modular bacteriocins, and hence speciﬁcity, depends on the
presence of speciﬁc outer membrane proteins (OMPs) exposed at the cellular surface.
Colicin M anchors to (certain loops of) the ferrichrome transporter FhuA and utilizes this
OMP for translocation into the periplasmic space (Table 1) (17, 46). This transfer
proceeds through the protein barrel, mediated by the TonB-ExbB-ExbD complex, is
energized by the proton motive force and likely requires (partial) protein unfolding for
barrel passage (17, 47–49). A short amino-terminal motif—referred to as the TonB
box—that is part of an unstructured amino-terminal part, is a key segment initiating
this transport (23, 50) (Fig. S2) and can be readily retrieved in virtually all ColM-type
bacteriocins. Despite sharing only low homologies in their respective RBDs, some other
ColM-type pseudocins from the ColM clade equally take advantage of the ferrichrome
transporter, in Pseudomonas called FiuA (37). Evolutionary sequence diversiﬁcation and
presumable target sharing by colicin M and (some) ColM-type pseudocins were previ-
ously postulated based on prominent structural similarities between the respective
bacteriocins (23). Based on high sequence similarities between amino-terminal do-
mains, it is also expected that a certain number of ColM-type bacteriocins in other
enterobacterial genera equally parasitize the ferrichrome receptor. An interesting
observation in this context is that homologous ColM pyocins, despite sharing high
sequence similarity (90% amino acid identity), do not target the same subset of bacteria
(25). Such an altered killing spectrum is likely due to allelic variation in FiuA (51).
In Pectobacterium and related genera (Brenneria and Dickeya), the RBD has been
replaced by a ferredoxin module (Pfam PF00111) (21), and for pectocin M1 in particular,
piracy of the bacterial plant ferredoxin receptor FusA has been demonstrated (52). As
opposed to other ColM bacteriocins, pectocins lack a TonB box for subsequent import,
and they possibly depend on FusB (a TonB homologue) for transfer to the periplasm
(32, 52). The observation that the integration of a ferredoxin module is detected in only
a limited set of taxonomically related organisms suggests that this module was
acquired more recently, possibly as a form of niche adaptation. For a distinct ColM-type
pyocin retrieved exclusively in P. aeruginosa (pyocin M4 [PaeM4], present in strain BL03
and many other isolates), a different receptor is expected since its RBD is signiﬁcantly
longer and lacks sequence similarity with respective domains from FiuA-binding ColM-
type pseudocins (Table 1) (25). The same is true for a second cluster of ColM
pseudocins (Pseudomonas ﬂuorescens HK44 as a representative [Fig. 1]) and distinct
enterobacterial ColM-type bacteriocins from Erwinia and Pantoea. To date, no receptor
has been identiﬁed for any of the ColM bacteriocins, and it remains to be investigated
whether ColM bacteriocins all target the same type of receptor.
The piracy of at least two different transporters involved in iron uptake underlines
the pivotal role of this metal ion in niche colonization by Enterobacteriaceae and other
proteobacteria, and a similar strategy is exploited by numerous bacteriocins and
phages. At this point, a straightforward prediction of the receptors likely targeted by
other ColM-type bacteriocins is complicated by the general lack of known domains
(except for the above-mentioned ferredoxin-containing pectocins). Diversifying recom-
bination events have led to a tremendous heterogeneity among nuclease bacteriocins
(5, 6, 8, 9, 38); for example, pyocins S1 and S6 share identical amino-terminal regions
but are equipped with an HNH-DNase and an rRNase domain, respectively (53). Colicins
B and D share a nearly identical amino-terminal region but are equipped with a
pore-forming and a tRNase domain, respectively, indicating that recombination events
between bacteriocins acting at different cellular levels (cell envelope and cytoplasm)
may occur equally (54). Also, in other polymorphic toxin systems, such as contact-
dependent growth inhibition (CDI)/antagonism cassettes, glycine zippers, MafB pro-
teins, Rhs effectors, and SitA lipoprotein toxins, recruitment of highly diverse toxin-
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immunity sets has been noted (18, 55–60). The extent to which such domain shufﬂing
has occurred equally for ColM-type bacteriocins deserves further scrutiny, but the
observations that (i) the ferredoxin module has also been recruited to a pesticin domain
(32) and (ii) the ColM module has been integrated in at least two hybrid bacteriocin
organizations validate ColM as a genuine building block in polymorphic toxins.
Toxin activation by permissive function. Following passage through the outer
membrane, full-length colicin M requires toxin refolding and activation by the peptidyl-
prolyl-cis-trans-isomerase FkpA (14, 61, 62). This modulating process requires FkpA’s
enzymatic activity, although the proline(s) affected has not been identiﬁed unambig-
uously (Fig. S2A) (63). FkpA chaperone processing is probably not a universal charac-
teristic among imported ColM-type bacteriocins, since there are no conserved proline
residues present in ColM domains. The residue likely isomerized by FkpA is present only
in a number of species taxonomically related to E. coli (Fig. S1). In support of that, it was
previously suggested that lytic activity of pectocin M1, when expressed in E. coli and
secreted to the periplasm, does not require FkpA for killing (29). It cannot be excluded,
however, that in some species another chaperone(s) provides assistance in activity-
generating folding.
Although the actual FkpA contribution in bacteriocin refolding remains partly
unsolved, such toxin activation by a permissive factor is not a unique observation. LepB
peptidase assists in FtsH-dependent cleavage of colicin D, resulting in release of the
tRNase domain, an essential step required for toxin entry into the cytoplasm (64, 65).
An E. coli tRNase effector delivered to target cells via CDI requires the cysteine
biosynthetic enzyme CysK (O-acetylserine sulfhydrylase A) for modulation of growth
inhibition (66), and RNase activity is displayed only when the toxin is bound to CysK.
This toxin stabilization organizes the active site for substrate recognition (67). For other
CDI tRNase toxins, GTP-dependent activation by elongation factor Tu (EF-Tu) was
detected (68, 69). From the producer’s perspective, activation necessity may seem an
undesirable trait, as toxin resistance may develop. For CDI toxins in particular, it was
suggested that such activation may play a role in intercellular communication (55):
toxins transferred to immune siblings could form heterotrimeric complexes (EF-Tu, CDI
toxin, and immunity partner) that inﬂuence gene expression and thereby cell-to-cell
signaling between clonally related cells (68, 69). Such a toxin exchange mechanism was
proposed to initiate bioﬁlm formation in Burkholderia thailandensis (70).
ColM protection provided by an amalgam of immunity partners. The ﬁrst ColM
immunity-providing protein to be identiﬁed was Cmi. This 117-aa protein contains a
periplasmic YebF-type module and is anchored in the cytoplasmic membrane with an
-helix (Table 1; Fig. 2A) (71–74). The YebF domain is typiﬁed by two cysteine residues
(75), required for Cmi folding and structure stabilization but not expected to contribute
to the immune function per se. Based on site-directed mutagenesis of surface-exposed
residues, a key role has been proposed for carboxy-terminal residues in Cmi (72).
Attempts to copurify and cocrystallize colicin M in complex with Cmi were unsuccessful;
therefore, it remains elusive how silencing of the ColM activity domain is actually
achieved (71). Candidate cmi orthologues with a YebF signature can be readily retrieved
in the vast majority of the enterobacterial isolates hosting ColM-type bacteriocin
genes (Fig. 1). As for E. coli, most cmi-like immunity genes are located downstream of
the bacteriocin gene, in the opposite direction (Fig. 2B). Occasionally, cmi may also be
located upstream, as, e.g., in Klebsiella variicola Kv6A2 and Enterobacter aerogenes
GN02525, which is rather atypical for polymorphic toxin organizations in general and
likely results from recombination events. In most pectobacteria, a cmi homologue is
genomically separated from the pectocin M gene (21), presumably resulting from
genome rearrangements. However, the potential role of the encoded protein in pro-
viding pectocin immunity remains to be explored.
Interestingly, pseudomonads do not carry cmi-like genes in their genomes (22).
Instead, immunity to bacteriocins of the ColM clade is provided by a different type of
protein, PmiA, adopting a four-transmembrane-helix (TMH) topology (Fig. 2A) (24), an
architecture that one would associate rather with immunity proteins for pore-forming
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bacteriocins (6, 8, 76). PmiAs are encoded downstream of the ColM-type pseudocin
genes and essentially do not show sequence conservation, except for a short semicon-
served motif that is predicted to be exposed to the periplasm. When mutated within
this motif, PmiA was found to still exert its function (24). Taking into account that Cmi
remains active in the periplasm when deprived of its membrane anchor (77), PmiA likely
shows immunity at a different cellular location, i.e., in the cytoplasmic membrane. Yet
another candidate immunity partner is expected for ColMs from Pantoea and Erwinia
(PeiB, Pantoea-Erwinia ColM-type immunity type B). These bacteriocin genes are asso-
ciated (upstream and downstream, respectively) with a gene encoding an immunity
protein with a similar topology as Cmi but lacking the YebF signature domain.
The majority of the ColM-type bacteriocin genes are associated with an immunity
partner adopting a similar topology as Cmi and PeiB, termed BmiB and PmiB in
Burkholderia and Pseudomonas, respectively (20, 24). Their periplasmic module again
lacks the YebF signature domain, cannot be meaningfully aligned with Cmi or PeiB, and
therefore possibly represents a third type of periplasmic ColM immunity domain. The
presence of two strictly conserved cysteines may point to disulﬁde bond formation, as
observed for Cmi (71, 72). Other ColM bacteriocins from Stenotrophomonas and
Luteibacter are equally associated with a putative bmiB/pmiB-type immunity gene,
FIG 2 (A) Membrane topology model of characterized and putative ColM-type immunity proteins. Sec/Tat-dependent signal sequences, if predicted in a
majority of the cases, are shown as a cylinder instead of a helix. IM, inner membrane; N, amino-terminal end. (B) Schematic gene organization of representative
ColM domain-containing bacteriocin and immunity genes (same color as gene products in panel A), including hybrid bacteriocins. The color code specifying
different domains and (putative) immunity partners and the scale in base pairs are deﬁned in the key at lower right. In the case of a candidate immunity gene
likely presented on a different locus, bacteriocin and immunity genes are separated by two slashes (immunity gene orientation is unknown). ColM-type
bacteriocins are boxed by a solid line, and ColM-type bacteriocins with unassigned phylogenetic positioning (Fig. 1) are boxed by a dashed line. Imn provides
immunity to the ColN pore-forming domain (37), and the carocin D immunity partner (carDI) provides immunity to the carocin D (CarD) DNase domain. The
ColM-type bacteriocin genes organized in tandem in Pantoea ananatis Sd-1 are speciﬁed by numerals 1 and 2 (Fig. 1).
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residing downstream on the same strand (Fig. 2A and B). The encoded proteins are
equipped with two cysteines as well, although obvious sequence similarity with BmiBs
and PmiBs is present only in the carboxy-terminal part of these candidate immunity
proteins. A small set of ColM-type burkhocins are associated (upstream or down-
stream) with a three-TMH immunity partner, BmiA (20), reminiscent of the PmiA
organization for ColM bacteriocins in pseudomonads. Given that ColM-BmiA orga-
nizations are rare and display close clustering (Fig. 1), one may speculate that this
immunity gene was acquired more recently during evolution. The candidate immunity
partner of the distinct ColM-type pyocin from P. aeruginosa BL03 (PmiC), encoded
downstream in the opposite direction, adopts yet another organization with six TMHs
(Fig. 2).
The ColM family: ﬁtting in the toxin-immunity coevolution model? The obser-
vation that the ColM domain has recruited different unrelated immunity genes is
surprising but does not necessarily argue against the toxin-immunity coevolution
model of diversifying selection. In this model, a ﬁrst mutation in an immunity gene
results in a broadened immunity function. Bacteriocin producers are now immune to
the ancestral bacteriocin but also have gained immunity to other similar toxin domains,
which is interesting from the producer’s point of view. A second mutation in the toxin
module may follow and does not necessarily have a negative impact on the diverged
immunity gene (78–80). Cells that do not host the new immunity gene are rapidly
outcompeted in this scenario, a process that keeps on repeating itself and eventually
results in diverged toxin families protected by their own cognate immunity gene. At
this point, there is no clear explanation why a multitude of immunity proteins have
been recruited by ColM-type bacteriocins, and such a phenomenon has not been
noticed for other polymorphic toxins so far. In Gram-positive bacteria, a similar obser-
vation has been made for the peptidoglycan-degrading bacteriocin 41 from Enterococ-
cus faecalis: two distinct immunity proteins have been described for this peptidoglycan
endopeptidase, equipped with two or four TMHs (81).
A number of options can be considered. (i) Part of the answer will likely be provided
by the interaction between the ColM domain and its chaperone(s) and the structural
consequences thereof. At this point, it cannot be excluded that ColMs (in different
genera/clusters) require different permissive factors. This is a reasonable assumption
considering the absence of a universally conserved proline in ColM domains (see
above). The interacting chaperone(s) may ultimately deﬁne which type of immunity
partner is required. (ii) Different immunity protein topologies may point to immunity at
different cellular locations, i.e., fundamentally different mechanisms would exist to
impede lipid II-degrading activity, targeting different patches of the ColM domain for
interaction, directly or indirectly impeding the enzymatic function. Considering that
integral membrane proteins in the ColM group arise only in pseudomonads and a
small subset of Burkholderia strains (ColM), this may suggest that immunity by this
type of protein was obtained later in evolution. (iii) The observations that the key
residues for Cmi immunity are located at the carboxy terminus of the protein and that
PmiAs sharing very poor sequence similarity with the cognate immunity protein may
provide noncognate immunity (24, 72) could result in a projective interpretation of the
relevance of immunity protein topology. Possibly, only a small patch is critical for
immunity. (iv) From an evolutionary point of view, the pressure to cotranscribe an
immunity gene together with a ColM-type bacteriocin is generally high and required
per se. Given that the genomic positioning of ColM bacteriocins is very diverse, even
within a certain genus, genetic coupling with a novel immunity partner may be the
fortuitous consequence of a seemingly unsuccessful recombination event. In this
scenario, ColM immunity was temporarily provided at a different locus, and in a later
phase replaced by a neofunctionalized bacteriocin-adjacent gene. This hypothesis may
explain why hybrid ColM-type bacteriocins exist and does not necessarily argue against
the classical interpretation of the toxin-immunity coevolution model, since diversifying
selection may still occur. (v) As lipid II tends to appear in regions of increased ﬂuidity
(RIFs), hereby forming “atoll”-like regions in the inner membrane, different immunity
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protein topologies may be the result of preferential (genus-dependent) association or
integration in these areas to protect lipid II from enzymatic digestion (16).
It will also be of future interest to explore whether kin selection is involved in
ColM-immunity divergence. This model states that genealogical relatives have more
alleles in common than nonrelated strains; therefore, the probability of maintaining a
gene in subsequent generations will increase if it is associated with an enhanced ﬁtness
for the genealogical relatives (55). Toxin-immunity modules, especially those for which
immunity is highly selective, as present in (certain) colicins and CDI cassettes, have
been previously studied in this context (55, 82–84).
Concluding remarks. Continued scrutiny of the E. coli ColM system along with
exploration of related systems from other proteobacterial genera has revealed ColM’s
catalytic site and noncatalytic activity, allowed delineation of structural domains that
may be the target of diversifying recombination and selection events, dissected the
contribution of a ﬁrst permissive factor, and revealed a whole array of topologically
distinct membrane-associated immunity proteins. The features emerging from this
broadened view are indicative of a genuine polymorphic toxin family and a patchwork
of immunity partners, giving rise to several new scientiﬁc questions and hypotheses.
The essentiality of lipid II for cell viability makes ColM bacteriocins an attractive
candidate drug worth exploring further.
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